Provision of Oncotype DX Breast Recurrence Score testing which addresses the issue of overtreatment with chemotherapy, particularly for patients with lymph nod-positive breast cancer.
This award stage contract from Gloucestershire Hospitals NHS Foundation Trust was published in 2026. The Send Away Test for Oncotype DX Breast Recurrence Score contract.
This UK government contract opportunity is part of the public procurement process, openly available via Find a Tender.
3 Feb
Published
Current
Award Phase
Contract value not disclosed
UK tender activity (12 months)
Provision of Oncotype DX Breast Recurrence Score testing which addresses the issue of overtreatment with chemotherapy, particularly for patients with lymph nod-positive breast cancer.
Ask the AI assistant for deeper analysis of this scope
Important deadlines and milestones
Tender opportunity made public on Find a Tender
This is a public procurement by Gloucestershire Hospitals NHS Foundation Trust. All UK government contracts are publicly accessible for transparency.
This Gloucestershire Hospitals NHS Foundation Trust contract has been awarded. Review for market intelligence.
Complete your profile for personalized match scoring
Analyze how well this tender matches your company profile and capabilities.
UK tender activity (12 months)
ocds-h6vhtk-061579RFP.quest helps UK businesses find and win public sector tenders. Our AI platform analyzes requirements, identifies gaps, and helps craft winning proposals.
AI-powered bid management
UK procurement tools
Expert guidance
Step-by-step guide
UK tender data from Find a Tender under the Open Government Licence. Powered by RFP.quest.
I can help you understand this Gloucestershire Hospitals NHS Foundation Trust contract:
• Requirements and evaluation criteria • Risks and gaps analysis • Buyer and market context • Related opportunities
Ask me anything about "Send Away Test for Oncotype DX Breast Recurrence Score"!
Powered by CopilotKit